Trending stocks: Cadila Healthcare shares rise nearly 3%

NEW DELHI: Shares of Cadila Healthcare traded 2.79 per cent up in Monday 's trade at 10:55AM (IST).
Around 202486 shares changed hands on the counter. The stock opened at Rs 325.95 and touched an intraday high and low of Rs 334.0 and Rs 320.95 , respectively, in the session so far.

The stock quoted a 52-week high of Rs 374.0 and a 52-week low of Rs 202.0 .

Drug firm Zydus Cadila said it has received tentative nod from the US health regulator to market generic Empagliflozin and Metformin Hydrochloride tablets, used for management of type-2 diabetes, in the American market.

Financials
Cadila Healthcare Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 33164.14 Crore) operating in Pharmaceuticals sector.

For the quarter ended 31-12-2019, the company reported a Consolidated sales of Rs 3534.50 Crore, up 8.95 % from last quarter Sales of Rs 3244.20 Crore and up .52 % from last year same quarter Sales of Rs 3516.10 Crore. The Company reported net profit after tax of Rs 364.40 Crore in latest quarter.

Cadila Healthcare Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 6207.00 Crore to Sales Value (95.59 % of Total Sales), Export Incentives which contributed Rs 169.30 Crore to Sales Value (2.60 % of Total Sales) and Other Operating Revenue which contributed Rs 116.40 Crore to Sales Value (1.79 % of Total Sales)for the year ending 31-Mar-2019.

Promoter holding
Promoters held 74.88 per cent stake in the company as of quarter ended 31st Dec 2019 .

Valuation ratio
It quoted a price-to-earnings ratio of 27.01 and price to book value of 2.89 .